Association of Polygenic Liability for Autism With Face-Sensitive Cortical Responses From Infancy | Autism Spectrum Disorders | JAMA Pediatrics | JAMA Network
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.173.234.169. Please contact the publisher to request reinstatement.
JAMA Network Home
JAMA Pediatrics
full text icon
Full Text
 contents icon
Contents
 figure icon
Figures /
Tables
 multimedia icon
Multimedia
 attach icon
Supplemental
Content
 references icon
References
 related icon
Related
 comments icon
Comments
1.
Kang  E, Keifer  CM, Levy  EJ, Foss-Feig  JH, McPartland  JC, Lerner  MD.  Atypicality of the N170 event-related potential in autism spectrum disorder: a meta-analysis.   Biol Psychiatry Cogn Neurosci Neuroimaging. 2018;3(8):657-666. doi:10.1016/j.bpsc.2017.11.003PubMedGoogle Scholar
2.
European Medicines Agency. Letter of support for N170 ERP as a prognostic biomarker for adaptive social functioning and its potential to stratify study populations in people with Autism spectrum disorders (ASD) without intellectual disability. Accessed February 24, 2021. https://www.ema.europa.eu/en/documents/other/letter-support-n170-erp-prognostic-biomarker-adaptive-social-functioning-its-potential-stratify_en.pdf.
3.
Tye  C, Bussu  G, Gliga  T,  et al; BASIS Team.  Understanding the nature of face processing in early autism: a prospective study.   medRxiv. Preprint posted online May 11, 2020. doi:10.1101/2020.05.06.20092619Google Scholar
4.
Gui  A, Mason  L, Gliga  T,  et al; BASIS-STAARS Team.  Look duration at the face as a developmental endophenotype: elucidating pathways to autism and ADHD.   Dev Psychopathol. 2020;32(4):1303-1322. doi:10.1017/S0954579420000930PubMedGoogle Scholar
5.
Grove  J, Ripke  S, Als  TD,  et al; Autism Spectrum Disorder Working Group of the Psychiatric Genomics Consortium; BUPGEN; Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium; 23andMe Research Team.  Identification of common genetic risk variants for autism spectrum disorder.   Nat Genet. 2019;51(3):431-444. doi:10.1038/s41588-019-0344-8PubMedGoogle Scholar
6.
Schork  AJ, Won  H, Appadurai  V,  et al.  A genome-wide association study of shared risk across psychiatric disorders implicates gene regulation during fetal neurodevelopment.   Nat Neurosci. 2019;22(3):353-361. doi:10.1038/s41593-018-0320-0PubMedGoogle Scholar
Comment
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
Submit Please Wait...
    New Online
    Views 762
    Citations 0
    Comments
    View Metrics
    Research Letter
    June 7, 2021

    Association of Polygenic Liability for Autism With Face-Sensitive Cortical Responses From Infancy

    Anna Gui, PhD1; Emma L. Meaburn, PhD2; Charlotte Tye, PhD3,4,5; et al Tony Charman, PhD6; Mark H. Johnson, PhD7; Emily J. H. Jones, PhD1
    Author Affiliations Article Information
    • 1Centre for Brain and Cognitive Development, Birkbeck College, University of London, London, United Kingdom
    • 2Department of Psychological Sciences, Birkbeck College, University of London, London, United Kingdom
    • 3Department of Psychology, King’s College London, London, United Kingdom
    • 4Department of Child & Adolescent Psychiatry, King’s College London, London, United Kingdom
    • 5Department of Psychology, King’s College London, London, United Kingdom
    • 6Department of Psychology, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, United Kingdom
    • 7Department of Psychology, Cambridge University, Cambridge, United Kingdom
    JAMA Pediatr. Published online June 7, 2021. doi:10.1001/jamapediatrics.2021.1338
    visual abstract icon
    Visual
    Abstract
     editorial comment icon
    Editorial
    Comment
     related articles icon
    Related
    Articles
     author interview icon
    Interviews
     multimedia icon
    Multimedia

    Autism is a heritable condition affecting 1% of people worldwide. Despite a pressing need for early intervention, the developmental paths through which genetic variants are associated with emerging behavioral symptoms in infancy remain opaque. The latency of the N170 event-related potential response to faces is replicably altered in individuals with autism1 and has potential as a stratification biomarker for prognostic social functioning.2 The N170 precursor (N290) to faces vs nonfaces is also altered prior to symptom emergence in infants subsequently diagnosed with autism.3 These early differences in brain processing represent a plausible developmental mechanism linking genetic liability and behavioral autism symptoms. We investigated whether N290 latency to faces vs nonfaces is associated with autism polygenic scores and cross-disorder polygenic scores in infants with and without a family history of autism.

    ×